KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Equity Ratio (2014 - 2026)

NovoCure recorded quarterly Equity Ratio of 0.42 in Q1 2026, down 0.84% quarter-over-quarter from 0.42 in Q4 2025, and up 44.81% year-over-year from 0.29 in Q1 2025.

NovoCure's Equity Ratio history runs 13 years deep, the most recent figure standing at 0.42 for Q1 2026.

  • In Q1 2026, Equity Ratio rose 44.81% year-over-year to 0.42; the TTM figure through Mar 2026 stood at 0.42 (up 44.81% YoY), while the FY2025 annual figure was 0.42, up 45.82% from the prior year.
  • Equity Ratio came in at 0.42 for Q1 2026 at NovoCure, down from 0.42 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.42 in Q4 2025 to a low of 0.25 in Q3 2025.
  • A 5-year average of 0.34 and a median of 0.34 in 2023 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio decreased 16.79% in 2024 and jumped 45.82% in 2025, its largest moves.
  • NovoCure's Equity Ratio stood at 0.37 in 2022, then fell by 14.57% to 0.32 in 2023, then declined by 8.22% to 0.29 in 2024, then surged by 45.82% to 0.42 in 2025, then decreased by 0.84% to 0.42 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.42, 0.42, and 0.25 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 NovoCure 1.90 Bn 1.47 Bn 135.13 Mn 0.42

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.42
Dec 31, 2025 0.42
Sep 30, 2025 0.25
Jun 30, 2025 0.28
Mar 31, 2025 0.29
Dec 31, 2024 0.29
Sep 30, 2024 0.30
Jun 30, 2024 0.30
Mar 31, 2024 0.32
Dec 31, 2023 0.32
Sep 30, 2023 0.34
Jun 30, 2023 0.36
Mar 31, 2023 0.37
Dec 31, 2022 0.37
Sep 30, 2022 0.38
Jun 30, 2022 0.38
Mar 31, 2022 0.38
Dec 31, 2021 0.36
Sep 30, 2021 0.37
Jun 30, 2021 0.36
Mar 31, 2021 0.35
Dec 31, 2020 0.45
Sep 30, 2020 0.71
Jun 30, 2020 0.51
Mar 31, 2020 0.48
Dec 31, 2019 0.45
Sep 30, 2019 0.43
Jun 30, 2019 0.39
Mar 31, 2019 0.34
Dec 31, 2018 0.33
Sep 30, 2018 0.36
Jun 30, 2018 0.36
Mar 31, 2018 0.35
Dec 31, 2017 0.43
Sep 30, 2017 0.44
Jun 30, 2017 0.46
Mar 31, 2017 0.49
Dec 31, 2016 0.50
Sep 30, 2016 0.54
Jun 30, 2016 0.75
Mar 31, 2016 0.79
Dec 31, 2015 0.82
Sep 30, 2015 0.70
Dec 31, 2014 0.83